Frontotemporal lobar degeneration: Old knowledge and new insight into the pathogenetic mechanisms of tau mutations

Giacomina Rossi, Fabrizio Tagliavini

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Frontotemporal lobar degeneration (FTLD) is a group of heterogeneous neurodegenerative diseases which includes tauopathies. In the central nervous system (CNS) tau is the major microtubule-associated protein (MAP) of neurons, promoting assembly and stabilization of microtubules (MTs) required for morphogenesis and axonal transport. Primary tauopathies are characterized by deposition of abnormal fibrils of tau in neuronal and glial cells, leading to neuronal death, brain atrophy and eventually dementia. In genetic tauopathies mutations of tau gene impair the ability of tau to bind to MTs, alter the normal ratio among tau isoforms and favor fibril formation. Recently, additional functions have been ascribed to tau and different pathogenetic mechanisms are then emerging. In fact, a role of tau in DNA protection and genome stability has been reported and chromosome aberrations have been found associated with tau mutations. Furthermore, newly structurally and functionally characterized mutations have suggested novel pathological features, such as a tendency to form oligomeric rather than fibrillar aggregates. Tau mutations affecting axonal transport and plasma membrane interaction have also been described. In this article, we will review the pathogenetic mechanisms underlying tau mutations, focusing in particular on the less common aspects, so far poorly investigated.

Original languageEnglish
Article number192
JournalFrontiers in Aging Neuroscience
Volume7
Issue numberOCT
DOIs
Publication statusPublished - 2015

Fingerprint

Frontotemporal Lobar Degeneration
Tauopathies
Mutation
Axonal Transport
Microtubules
Aptitude
Brain Death
Microtubule-Associated Proteins
Genomic Instability
Morphogenesis
Neuroglia
Chromosome Aberrations
Neurodegenerative Diseases
Atrophy
Dementia
Protein Isoforms
Central Nervous System
Cell Membrane
Neurons
DNA

Keywords

  • Frontotemporal lobar degeneration
  • MAPT
  • Mutation
  • Pathogenetic mechanisms
  • Tau
  • Tauopathies

ASJC Scopus subject areas

  • Ageing
  • Cognitive Neuroscience

Cite this

@article{41f66492db484025b4448bde1945083d,
title = "Frontotemporal lobar degeneration: Old knowledge and new insight into the pathogenetic mechanisms of tau mutations",
abstract = "Frontotemporal lobar degeneration (FTLD) is a group of heterogeneous neurodegenerative diseases which includes tauopathies. In the central nervous system (CNS) tau is the major microtubule-associated protein (MAP) of neurons, promoting assembly and stabilization of microtubules (MTs) required for morphogenesis and axonal transport. Primary tauopathies are characterized by deposition of abnormal fibrils of tau in neuronal and glial cells, leading to neuronal death, brain atrophy and eventually dementia. In genetic tauopathies mutations of tau gene impair the ability of tau to bind to MTs, alter the normal ratio among tau isoforms and favor fibril formation. Recently, additional functions have been ascribed to tau and different pathogenetic mechanisms are then emerging. In fact, a role of tau in DNA protection and genome stability has been reported and chromosome aberrations have been found associated with tau mutations. Furthermore, newly structurally and functionally characterized mutations have suggested novel pathological features, such as a tendency to form oligomeric rather than fibrillar aggregates. Tau mutations affecting axonal transport and plasma membrane interaction have also been described. In this article, we will review the pathogenetic mechanisms underlying tau mutations, focusing in particular on the less common aspects, so far poorly investigated.",
keywords = "Frontotemporal lobar degeneration, MAPT, Mutation, Pathogenetic mechanisms, Tau, Tauopathies",
author = "Giacomina Rossi and Fabrizio Tagliavini",
year = "2015",
doi = "10.3389/fnagi.2015.00192",
language = "English",
volume = "7",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Research Foundation",
number = "OCT",

}

TY - JOUR

T1 - Frontotemporal lobar degeneration

T2 - Old knowledge and new insight into the pathogenetic mechanisms of tau mutations

AU - Rossi, Giacomina

AU - Tagliavini, Fabrizio

PY - 2015

Y1 - 2015

N2 - Frontotemporal lobar degeneration (FTLD) is a group of heterogeneous neurodegenerative diseases which includes tauopathies. In the central nervous system (CNS) tau is the major microtubule-associated protein (MAP) of neurons, promoting assembly and stabilization of microtubules (MTs) required for morphogenesis and axonal transport. Primary tauopathies are characterized by deposition of abnormal fibrils of tau in neuronal and glial cells, leading to neuronal death, brain atrophy and eventually dementia. In genetic tauopathies mutations of tau gene impair the ability of tau to bind to MTs, alter the normal ratio among tau isoforms and favor fibril formation. Recently, additional functions have been ascribed to tau and different pathogenetic mechanisms are then emerging. In fact, a role of tau in DNA protection and genome stability has been reported and chromosome aberrations have been found associated with tau mutations. Furthermore, newly structurally and functionally characterized mutations have suggested novel pathological features, such as a tendency to form oligomeric rather than fibrillar aggregates. Tau mutations affecting axonal transport and plasma membrane interaction have also been described. In this article, we will review the pathogenetic mechanisms underlying tau mutations, focusing in particular on the less common aspects, so far poorly investigated.

AB - Frontotemporal lobar degeneration (FTLD) is a group of heterogeneous neurodegenerative diseases which includes tauopathies. In the central nervous system (CNS) tau is the major microtubule-associated protein (MAP) of neurons, promoting assembly and stabilization of microtubules (MTs) required for morphogenesis and axonal transport. Primary tauopathies are characterized by deposition of abnormal fibrils of tau in neuronal and glial cells, leading to neuronal death, brain atrophy and eventually dementia. In genetic tauopathies mutations of tau gene impair the ability of tau to bind to MTs, alter the normal ratio among tau isoforms and favor fibril formation. Recently, additional functions have been ascribed to tau and different pathogenetic mechanisms are then emerging. In fact, a role of tau in DNA protection and genome stability has been reported and chromosome aberrations have been found associated with tau mutations. Furthermore, newly structurally and functionally characterized mutations have suggested novel pathological features, such as a tendency to form oligomeric rather than fibrillar aggregates. Tau mutations affecting axonal transport and plasma membrane interaction have also been described. In this article, we will review the pathogenetic mechanisms underlying tau mutations, focusing in particular on the less common aspects, so far poorly investigated.

KW - Frontotemporal lobar degeneration

KW - MAPT

KW - Mutation

KW - Pathogenetic mechanisms

KW - Tau

KW - Tauopathies

UR - http://www.scopus.com/inward/record.url?scp=84946548867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946548867&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2015.00192

DO - 10.3389/fnagi.2015.00192

M3 - Article

AN - SCOPUS:84946548867

VL - 7

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - OCT

M1 - 192

ER -